Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SS-1 for Sjögren's Syndrome
NCT02110446Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Feb 2014
- Primary completion
- Jul 2016
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sjögren's syndrome comparing SS-1 First with Placebo First (2 arms). Primary endpoints: Ocular Surface Disease Index at 7 months, EULAR Sjögren's Syndrome Patient Reported Index at 7 months and 3 more. Status: unknown.
02
Drugs
SS-1
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT02110446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02110446.